Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ferric Carboxymaltose (Ferinject®) Administered After Cardiac Surgery: (FCAACS) Effects On Correction Of Anemia And Transfusion Rates: A Prospective Randomized Controlled Trial

NCT03759964 is registered in ClinicalTrials.gov with St Joseph University, Beirut, Lebanon as lead sponsor.

NCT NCT03759964
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03759964 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ferric Carboxymaltose (Ferinject®) Administered After Cardiac Surgery: (FCAACS) Effects On Correction Of Anemia And Transfusion Rates: A Prospective Randomized Controlled Trial
Lead sponsor
St Joseph University, Beirut, Lebanon
Phase
Phase 4
Overall status
Completed
Start date
December 15, 2018
Completion date
January 2, 2021
Enrollment
194 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, iron deficiency